SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

Aircoin is trending due to anticipation surrounding the upcoming "AirLock" release, which aims to give the community control over the token's supply. Community members are actively discussing the project's transparent leadership, strong fundamentals, and potential for long-term growth within the Solana ecosystem. The project is also engaging with the community through frequent X spaces.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to renewed interest in its low float and a prior AI server deal, sparking discussions about potential short squeezes and comparisons to other recent runners. The community is focused on accumulation patterns and key breakout levels, anticipating a significant price move. Some traders speculate about the impact of upcoming news and the potential for a multi-day run.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token ($YEE) is trending due to a surge in community enthusiasm and bullish sentiment, with many believing it's poised for a significant breakout within the Ethereum ecosystem. Discussions highlight its strong community, potential as the next major meme coin like $PEPE, and a narrative tied to a long-term crypto prophecy. The community emphasizes the token's potential to bring value and attention back to the Ethereum blockchain.

Assemble’s AI agent, News3(NS3), was developed with the goal of revolutionizing Web 3.0 journalism. NS3 delivers crypto and global economic trends quickly and clearly, and leverages advanced AI reasoning capabilities to analyze these trends, enabling market participants to make data-driven decisions. In particular, NS3 utilizes OpenAI’s latest reasoning model as its core engine to analyze crypto and economic trends, providing a range of insights including market psychology, past case analysis, future predictions, ripple effects, and investment strategies in 12 languages.

Assemble Protocol

Assemble Protocol ($ASM) is trending amidst community excitement around potential AI developments and speculation of a surge. Community members are actively discussing accumulating coins, with some anticipating a significant price increase soon.  The conversation includes mentions of partnerships and technical analysis, while the overall sentiment appears cautiously optimistic.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta Crypto ($KTA) is trending due to discussions comparing it to established cryptocurrencies and financial platforms like Coinbase and Bitcoin. Community members are highlighting Keeta's high transaction throughput, compliance-first architecture, and integration with Bridge (a Stripe company) for seamless fiat on/off-ramps. The conversation focuses on Keeta's potential as a foundational infrastructure layer for institutional adoption and cross-chain compatibility.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending due to its vibrant and active community rallying around the meme-driven project, with community members excitedly anticipating 'THE AGENDA' reveal on Monday the 15th. The coin, born from $PUMP on Solana, is praised for its organic growth, strong community, and consistent meme creation, leading to bullish sentiment and a shared belief in its potential for significant growth, possibly eyeing 2026.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

DOT is trending as community members discuss its interoperability and potential, especially when compared to other Layer 1 solutions. The conversation centers around how DOT can complement other chains, with some suggesting allocation strategies for a diversified portfolio. Despite positive sentiment, some traders express frustration with DOT's price action and compare it unfavorably to other crypto assets.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

UNI is trending due to community excitement around potential token burn mechanisms and fee switch proposals, which could significantly reduce circulating supply and reward holders. Discussions highlight UNI's established role in DeFi, while also considering the potential impact of emerging infrastructure solutions like Keeta, which focus on compliance and high-throughput capabilities for institutional adoption. Investors are weighing UNI's strengths against the broader evolution of the DeFi landscape.

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.

Zenas Biopharma Inc.

ZBIO is experiencing increased attention following positive Phase 2 clinical trial results for its multiple sclerosis drug, obexelimab, showing a significant reduction in new lesions compared to placebo. This has fueled investor optimism and buying interest, with some analysts adjusting their rating to 'Outperform' and setting higher price targets. The community is also discussing a potential short squeeze, given the stock's high short interest.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is trending as investors assess its strategic direction, highlighted by news of cost control and Aetna's performance in Medicare Advantage. Community discussions revolve around CVS's valuation compared to peers and potential upside related to recent developments and analyst upgrades. The stock is viewed as a defensive play with potential for continued growth in the healthcare sector, though some concerns remain regarding PBM regulations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BMEA added 10k shares on top of my 30k. One of the most misunderstood and undervalued biotech names currently. $SMMT is the other.

Dusko Dakic

Bigpapa46

Glenn Thomas

Pete

Rick Bracey

EB2224

K.Richard

charlief

StockTwits Web

Biomea Fusion Inc

Summit Therapeutics Inc

 added 10k shares on top of my 30k. One of the most misunderstood and undervalued biotech names currently. 

BigBeardTrader

@BigBeardTrader Whats the storie on this stock ?

StockTwits For Android 

TruthBroker

@TruthBroker2 BMEA is a very small diabetes and obesity company built around a drug designed to help the body restore its own insulin producing ability instead of relying on symptom management. Early results look promising, showing benefits that last well beyond the treatment window. The idea is it changes the disease not just treating it. but the studies are still small and the valuation reflects both the high risk and the potential for a big upside if larger trials confirm the effect. I have 40k shares. I think the buzz is enough to bring in some big players also considering its current market cap is like 100 mil.

StockTwits for iOS

 BMEA is a very small diabetes and obesity company built around a drug designed to help the body restore its own insulin producing ability instead of relying on symptom management. Early results look promising, showing benefits that last well beyond the treatment window. The idea is it changes the disease not just treating it. but the studies are still small and the valuation reflects both the high risk and the potential for a big upside if larger trials confirm the effect. I have 40k shares. I think the buzz is enough to bring in some big players also considering its current market cap is like 100 mil.

@BigBeardTrader Ok Thank you ill check it out .Hope you have that many shares of Smmt big Payout coming soon 👍

 Ok Thank you ill check it out .Hope you have that many shares of Smmt big Payout coming soon 👍